Pharmaceuticals Division, Bayer AG, Berlin, Germany.
, Berlin, Germany.
Sci Rep. 2021 Dec 1;11(1):23257. doi: 10.1038/s41598-021-02719-9.
The aim of this study was to investigate effects of high LET α-radiation in combination with inhibitors of DDR (DNA-PK and ATM) and to compare the effect with the radiosensitizing effect of low LET X-ray radiation. The various cell lines were irradiated with α-radiation and with X-ray. Clonogenic survival, the formation of micronuclei and cell cycle distribution were studied after combining of radiation with DDR inhibitors. The inhibitors sensitized different cancer cell lines to radiation. DNA-PKi affected survival rates in combination with α-radiation in selected cell lines. The sensitization enhancement ratios were in the range of 1.6-1.85 in cancer cells. ATMi sensitized H460 cells and significantly increased the micronucleus frequency for both radiation qualities. ATMi in combination with α-radiation reduced survival of HEK293. A significantly elicited cell cycle arrest in G/M phase after co-treatment of ATMi with α-radiation and X-ray. The most prominent treatment effect was observed in the HEK293 by combining α-radiation and inhibitions. ATMi preferentially sensitized cancer cells and normal HEK293 cells to α-radiation. DNA-PKi and ATMi can sensitize cancer cells to X-ray, but the effectiveness was dependent on cancer cells itself. α-radiation reduced proliferation in primary fibroblast without G/M arrest.
本研究旨在探讨高传能线密度(linear energy transfer,LET)α 射线与 DNA 损伤修复(DNA damage repair,DDR)抑制剂联合作用的影响,并将其与低 LET X 射线的放射增敏效应进行比较。用 α 射线和 X 射线照射各种细胞系。用 DDR 抑制剂联合照射后,研究集落形成、微核形成和细胞周期分布。抑制剂使不同的癌细胞系对辐射敏感。在选定的细胞系中,DNA-PKi 与 α 射线联合影响存活率。在癌细胞中,增敏增强比在 1.6-1.85 范围内。ATMi 增敏 H460 细胞,并显著增加两种辐射质量的微核频率。ATMi 与 α 射线联合处理减少了 HEK293 的存活。在 ATMi 与 α 射线和 X 射线联合处理后,细胞周期明显停滞在 G2/M 期。在 HEK293 中观察到最显著的治疗效果。ATMi 优先使癌细胞和正常的 HEK293 细胞对 α 射线敏感。DNA-PKi 和 ATMi 可使癌细胞对 X 射线敏感,但有效性取决于癌细胞本身。α 射线在没有 G2/M 阻滞的情况下减少原代成纤维细胞的增殖。